Gebrüder Weiss Expands into Thailand
International Logistics company continues to expand its network in South-East Asia to provide air and sea freight transportation, customs handling and cross-border land transport
Bangkok, Thailand and Lauterach, Austria--(Newsfile Corp. - May 30, 2025) - Gebrüder Weiss is set to open a new country organization in Thailand on June 1, 2025. The international transport and logistics company is strengthening its market presence in Southeast Asia and expanding its network in one of the world's most economically dynamic regions.
'The new country organization allows us to close a strategic gap and create direct connections to central Asia-Pacific markets for our customers,' says Lothar Thoma, Managing Director Air & Sea at Gebrüder Weiss. 'Thailand is an important export location with strong trade links to the USA, China, Japan, Australia, and Singapore - markets where we are also represented with locations of our own.'
In 2024, Thailand posted export volumes worth approximately $ 300 billion, up 5 percent from the previous year. Industrial goods account for the majority of outbound trade at 86 percent, with key categories including electronics, vehicles, machinery, and food.
The team of 20 employees in Bangkok provides international air and sea freight transportation, customs handling, and national and cross-border land transport services. 'Our employees have many years of experience in international transport management. In the medium term, we are aiming to expand our services in Thailand to include warehouse logistics, with a particular focus on the automotive and high-tech sectors,' says Cristian Predan, Director South-East Asia at Gebrüder Weiss.
With its entry into the Thai market, Gebrüder Weiss now has an active presence in nine countries across the East and South-East Asia region and Oceania. These include Australia, Greater China, Japan, Malaysia, New Zealand, Singapore, South Korea, and Vietnam. The regional network now spans 35 locations with around 800 employees.
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_003.jpg ]
Gebrüder Weiss opens a new location in Thailand. Here: the team in Bangkok. (Source: Gebrüder Weiss)
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_003full.jpg
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_004.jpg ]
Laem Chabang container port is Thailand's most important seaport and a central hub for international trade. (Source: GettyImages)
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_004full.jpg
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_005.jpg ]
Lothar Thoma, Managing Director Air & Sea at Gebrüder Weiss (Source: Gebrüder Weiss / Ohligschläger)
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_005full.jpg
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_006.jpg ]
Cristian Predan, Director South-East Asia at Gebrüder Weiss. (Source: Gebrüder Weiss / Serra)
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_006full.jpg
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_007.jpg ]
From Tokyo to Sydney: The Gebrüder Weiss network in China, South-East Asia, and Oceania includes 35 locations. (Source: Gebrüder Weiss)
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_007full.jpg
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_008.jpg ]
Gebrüder Weiss locations in Australia and New Zealand (source: Gebrüder Weiss)
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10370/253912_c165ea04048e88e7_008full.jpg
About Gebrüder Weiss
Gebrüder Weiss, a global freight forwarder with a core business of overland transport, air, and sea freight and logistics, is the world's oldest transport company with a history that dates back more than half a millennium. The family-owned company employs more than 8,600 people worldwide and boasts 180 company-owned locations. The business presence in North America includes headquarters in Chicago and offices in Atlanta, Boston, Dallas, Denver, El Paso, Houston, Laredo, Los Angeles, Miami, New York, Phoenix, Salt Lake City, San Francisco, Montreal, Toronto, and Vancouver. The company has implemented a wide range of environmental, economic, and social initiatives and is recognized as a pioneer in sustainable business practices. The company's emphasis on superior customer service pairs customized solutions with a single point of contact to provide customers with focused, reliable, and efficient strategic solutions. www.gw-world.com/us
North American Contact:
Karolyn Raphael
Public Relations for Gebrüder Weiss
[email protected]
312-494-0422
www.gw-world.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/253912
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Toyota's 2026 Camry: Now With 100% More Sass and Attitude
Toyota's bringing the Nightshade trim to the 2026 Camry, and it's more than just a style play. It's still hybrid-only, which means top-tier fuel economy without sacrificing punch. This ninth-gen Camry shows up with sharp new looks and performance tweaks that go beyond surface level. It's got a revamped powertrain, electric all-wheel drive, and those stealthy blacked-out Nightshade vibes. This isn't the Camry you remember from family road trips. Whether you're chasing efficiency, edge, or a solid daily driver, the 2026 Camry might catch you off guard—in a good way. Toyota's best-selling sedan is turning up the attitude for 2026 with the new Camry Nightshade Edition. This stealthy, aggressive trim joins the ninth-generation lineup with a fresh dose of edge. Built on Toyota's all-hybrid Camry platform, the Nightshade stands out with blacked-out details, 19-inch black alloy wheels, and Midnight Black Metallic accents everywhere from the grille to the diffuser. It comes in three bold color options: Ice Cap, Supersonic Red, and Midnight Black Metallic—each pairing eye-catching design with hybrid efficiency. Under the hood, every 2026 Camry gets Toyota's fifth-gen hybrid system, combining a 2.5-liter 4-cylinder engine with an electric motor. It delivers 225 horsepower in front-wheel drive and 232 in all-wheel drive. Toyota has tweaked the setup for smoother, more natural acceleration. Plus, a recalibrated e-CVT improves throttle response while keeping fuel economy sky-high—up to 51 mpg combined in the FWD LE model. For extra traction and peace of mind, Electronic On-Demand AWD is now available on all five Camry trims—LE, SE, XLE, XSE, and Nightshade. Instead of a mechanical driveshaft, it uses a rear-mounted electric motor, making the system lighter, quicker to respond, and 30 horsepower stronger than before. Whether you're navigating slick roads or winding backroads, the AWD setup helps deliver better grip, stability, and sharper steering. It's smart enough to send torque where it's needed, exactly when it's needed. Design-wise, the 2026 Camry gets a serious glow-up. Created by CALTY Design Studios in California and Michigan, the new look includes a bold hammerhead front fascia, standard LED lighting, and a lower, more streamlined stance. Each trim brings its own flair with unique grille and wheel designs. The SE and XSE trims go sportier with mesh grilles, dual exhaust tips, aerodynamic accents, and blacked-out details—plus, the XSE adds a slick two-tone option with a black roof and bold colors like Supersonic Red and the new Dark Cosmos. Inside, each Camry trim brings its own vibe—from the LE's clean, minimalist layout to the XLE's more premium feel with upscale materials. Sportier models like the SE and XSE add flair with contrast stitching, paddle shifters, and supportive bolstered seats. Across the board, the 2026 Camry is packed with standard tech and safety features. Toyota's newest infotainment system comes with an 8-inch screen or an optional 12.3-inch upgrade for those who want a bit more. We already love what Toyota did with the 2025 Prius Nightshade, and the Camry seems ready to follow suit. The full 2026 Camry lineup, including the sleek Nightshade Edition, lands in dealerships fall 2025—with pricing to be revealed closer to launch. With bold styling, improved hybrid power, and optional all-wheel drive, this is the most capable Camry yet. And for those craving something with a little more attitude, the Nightshade might just be the one to watch. Source: Toyota, HotCars
Yahoo
42 minutes ago
- Yahoo
Avistone Announces Encouraging Results for Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression at ASCO Annual Meeting 2025
BEIJING, May 31, 2025--(BUSINESS WIRE)--Beijing Avistone Biotechnology Co., Ltd ("Avistone"), an innovative biotechnology company focused on precision oncology therapeutics, today announced that the clinical data for Vebreltinib plus Andamertinib (PLB1004), its innovative combination of potent mesenchymal-epithelial transition factor (MET) inhibitor and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), has been presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025. The details of the poster presentation are provided below: Poster title: Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression after failure on EGFR-TKIs treatment: phase Ib/II KYLIN-1 studyAbstract Number For Publication: 8632Session: Poster Session-Lung Cancer- Non-Small Cell MetastaticLocation: Poster Board, 112Session Date/Time: 5/31/2025 1:30pm-4:30pm CDT MET amplification or overexpression is the most common "off-target" mechanism that drives resistance to EGFR-TKIs in NSCLC patients. The results from Phase Ib/II KYLIN-1 study (NCT06343064) showed that Vebreltinib plus Andamertinib demonstrated notable efficacy and manageable safety in EGFR-mutated NSCLC patients with MET amplification or overexpression after EGFR-TKIs failure. Among the 56 patients enrolled at a dose of Vebreltinib 150mg BID plus Andamertinib 80mg QD (RP2D), the confirmed overall response rate (ORR) was 50.0%, and the median progression-free survival (mPFS) was 9.9 months. In 19 patients with brain metastases, ORR was 42.1% and mPFS was 9.5 months. Grade 3 or higher treatment related adverse events (TRAEs) occurred in 19.6% of the patients. None discontinued treatment or died due to TRAEs. No new safety signal was observed. A multicenter Phase III study, KYLIN-3 study (NCT06970782), is currently ongoing to further evaluate Vebreltinib plus Andamertinib versus platinum-based doublet chemotherapy in patients with EGFR mutations, MET amplification and/or overexpression, locally advanced or metastatic NSCLC following EGFR-TKI failure. To obtain a copy of the poster, please email Avistone. About Vebreltinib Vebreltinib is an orally, potent and selective c-Met inhibitor. Chinese National Medical Products Administration (NMPA) has formally approved the use of Vebreltinib in locally advanced or metastatic NSCLC patients with MET exon 14 skipping mutations, as well as adult patients with isocitrate dehydrogenase mutant astrocytoma with the PTPRZ1-MET fusion gene or glioblastoma with a history of low-grade disease who have the PTPRZ1-MET fusion gene and have failed previous treatments. Currently, Chinese Center for Drug Evaluation (CDE) has formally accepted its New Drug Application (NDA) and granted it priority review, intended for patients with locally advanced or metastatic NSCLC with MET amplification. About Andamertinib (PLB1004) Andamertinib (PLB1004) is an oral, potent, irreversible, and selective EGFR-TKI with potent blood-brain barrier penetration and broad tyrosine kinase activity. Preclinical studies have shown that it can effectively and irreversibly target exon 20 insertion. Additionally, it can also potently target classical EGFR mutations, such as Del19, L858R and T790M with a high degree of selectivity. About Avistone Biotechnology Beijing Avistone Biotechnology Co., Ltd. ("Avistone") is an innovative biotechnology company dedicated to precision therapies with significant unmet medical needs for patients worldwide. Avistone maintains an extensive pipeline of targeted therapies in Non-Small Cell Lung Cancer (NSCLC) and other solid tumors. View source version on Contacts BD@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
TSMC Stock Maintains High-Conviction AI Play Status With $220 Price Target
Taiwan Semiconductor Manufacturing Company (TSM), or TSMC for short, the world's numero uno pure-play semiconductor foundry, has surged nearly 20% over the past month. Despite this impressive rally, my outlook remains bullish. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The company is well-positioned to benefit from powerful tailwinds, including relentless AI-driven demand, a dominant—nearly monopolistic—position in advanced chip manufacturing, ongoing geographic diversification, and a steady cadence of technological breakthroughs. TSMC continues to be the principal manufacturer and primary supplier of chips for leading AI powerhouses, including Nvidia (NVDA), Advanced Micro Devices (AMD), Apple (AAPL), and Qualcomm (QCOM). Notably, TSM is also the producer of Nvidia's cutting-edge Blackwell chip series, which has recently gained immense popularity. TSMC's 3nm process currently represents the most advanced semiconductor technology in the industry, delivering superior power efficiency and performance. Looking ahead, anticipation is building around the company's upcoming 2nm and 1.6nm nodes, scheduled for launch in late 2025 and 2026, respectively. The 2nm technology, referred to as N2, remains on track for volume production in the second half of 2025. This next-generation process is expected to deliver a 10–15% improvement in processing speed at the same power consumption, or a 20–30% reduction in power usage at equivalent performance. Following that, the 1.6nm process is projected to further improve power efficiency by an additional 15–20% over the 2nm node. These advancements are especially timely, as data centers grapple with rising energy costs. The shift to more power-efficient chips is becoming not only a technological imperative but also an economic necessity. This positions TSMC as a key enabler in the ongoing global semiconductor upgrade cycle. Reflecting this momentum, TSMC has outlined strong long-term growth expectations. The company projects its AI-related chip revenue to grow at a compound annual growth rate (CAGR) of 45% over the next five years, while overall revenue is forecast to grow at a 20% CAGR during the same period. These figures underscore the company's pivotal role in powering the future of computing. Such growth potential hasn't gone unnoticed. Famous investor Cathie Wood's Ark funds recently purchased 241,047 shares of Taiwan Semiconductor, worth $46.3 million, signaling firm institutional conviction. TSM commands an overwhelming 64.9% global market share in the foundry segment, dwarfing its closest competitors— Samsung Electronics (SMSN) and Intel (INTC), according to Statista. Its unparalleled scale, deep client relationships, and technological edge create formidable barriers to entry. This dominant position grants TSM significant pricing power. Clients, many of whom have relied on TSM for decades, are unlikely to switch suppliers given the risk of falling behind in the rapidly evolving AI race. One of the major risk factors associated with TSM is its geographical location in Taiwan, which poses the risk of a takeover by China. However, TSM is prioritizing geographic diversification as a core strategic initiative, proactively addressing these risks by diversifying its global manufacturing footprint. In addition to its $65 billion investment in U.S.-based fabs, TSM has committed a further $100 billion to expand capacity globally. Its Arizona facility is reportedly operating at full capacity through 2027, highlighting robust demand. This geographic diversification not only reduces exposure to potential tariffs but also strengthens TSM's resilience to geopolitical volatility. Beyond the U.S., TSM is also establishing a new chip design center in Munich, Germany, as well as a manufacturing plant in Dresden, Germany, and new fabs in Japan. Taiwan Semiconductor's strategic investments beyond its home base reflect prudent risk management and reinforce its strategic shift toward a more balanced global presence. TSM is set to report its Q2 2025 earnings on July 17. The company is projected to report earnings per share (EPS) of $2.30, representing a 57.5% year-over-year increase. Additionally, Q2 revenues are projected to increase by 13% year-over-year, ranging between $28.4 billion and $29.2 billion, driven by high demand for its advanced 3-nanometer (nm) and 5-nm processes. On May 9, TSM unveiled impressive revenue figures for April 2025, marking the highest ever figure in any single month in the company's history. April net revenues galloped 48.1% year-over-year to 349.6 billion New Taiwan dollars (approximately $11.6 billion). It's worth noting that TSM anticipates 24% to 26% sales growth for FY2025, driven by strong demand for its latest nanochips amid the AI surge. Importantly, TSM trades at an attractive valuation compared to its peers. In terms of its valuation, TSM looks cheap. Currently, it's trading at an attractive forward P/E ratio of 21x, compared to much higher multiples of its peer group. Semiconductor company Advanced Micro Devices is trading at a higher forward P/E multiple (28x), while the AI prodigy Nvidia is trading at a forward P/E of 32x. On Wall Street, TSM stock carries a Strong Buy consensus rating based on seven Buy, one Hold, and zero Sell ratings over the past three months. TSM's average stock price target of $219.43 implies approximately 11% upside potential over the next twelve months. The semiconductor industry continues to experience strong growth, driven largely by the rapid adoption of artificial intelligence technologies. TSMC, with its unmatched manufacturing capabilities, deeply embedded customer relationships, and advanced technology roadmap, is exceptionally well-positioned to capitalize on this transformative trend. The company's timely investments in next-generation nodes—specifically 2nm and 1.6nm—alongside its global manufacturing expansion, align well with rising demand fueled by a broad upgrade cycle across the tech landscape. These factors collectively make TSMC a compelling long-term investment opportunity. With a favorable valuation and strong earnings momentum, the current environment presents an attractive entry point for investors looking to gain exposure to the accelerating AI megatrend. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
